Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome
- PMID: 15978137
- PMCID: PMC1188078
- DOI: 10.1186/1479-5876-3-26
Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome
Abstract
Nasopharyngeal carcinoma (NPC) is a tumor derived from epithelial cells and Epstein-Barr virus infection has been reported to be a cause of this disease. Chemokine receptor CXCR4 was found to be involved in HIV infection and was highly expressed in human malignant breast tumors and the ligand for CXCR4, CXCL12 (SDF-1), exhibited high expression in organs in which breast cancer metastases are often found. The metastatic pattern of NPC is quite similar to that of malignant breast tumors. In this study, we investigated the expression of CXCR4 in nasopharyngeal carcinoma (NPC) tissues by immunohistostaining. We found different staining patterns, which included localization in the nucleus, membrane, cytoplasm or a combination of them. The staining intensity was also variable among samples. The metastatic rates in patients with high compared to low or absent expression was 38.6% versus 19.8%, respectively (P = 0.004). High expression of CXCR4 was associated with poor overall survival (OS = 67.05% versus 82.08%, P = 0.0225). These results suggest that CXCR4 may be involved in the progression of NPC and that a high level of CXCR4 expression could be used as a prognostic factor.
Figures


Similar articles
-
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.Gynecol Oncol. 2006 Oct;103(1):226-33. doi: 10.1016/j.ygyno.2006.02.036. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16631235
-
Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy.J Pathol. 2006 Nov;210(3):363-73. doi: 10.1002/path.2053. J Pathol. 2006. PMID: 16955398
-
Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.Biochem Biophys Res Commun. 2006 Jul 21;346(1):252-8. doi: 10.1016/j.bbrc.2006.05.110. Epub 2006 May 26. Biochem Biophys Res Commun. 2006. PMID: 16756955
-
The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.Clin Cancer Res. 2005 Jul 1;11(13):4658-65. doi: 10.1158/1078-0432.CCR-04-1798. Clin Cancer Res. 2005. PMID: 16000558
-
[The role of SDF-1 and its receptor CXCR4 in tumor metastasis].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2007 Oct;24(5):1180-3. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2007. PMID: 18027722 Review. Chinese.
Cited by
-
CXCR4 knockdown inhibits the growth and invasion of nasopharyngeal cancer stem cells.Oncol Lett. 2017 Apr;13(4):2253-2259. doi: 10.3892/ol.2017.5694. Epub 2017 Feb 8. Oncol Lett. 2017. PMID: 28454388 Free PMC article.
-
Nuclear expression of CXCR4 is associated with advanced colorectal cancer.Int J Colorectal Dis. 2010 Oct;25(10):1185-91. doi: 10.1007/s00384-010-0999-1. Epub 2010 Jul 7. Int J Colorectal Dis. 2010. PMID: 20607251
-
Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases.Pharmaceuticals (Basel). 2021 May 7;14(5):439. doi: 10.3390/ph14050439. Pharmaceuticals (Basel). 2021. PMID: 34066915 Free PMC article. Review.
-
Location Bias as Emerging Paradigm in GPCR Biology and Drug Discovery.iScience. 2020 Oct 7;23(10):101643. doi: 10.1016/j.isci.2020.101643. eCollection 2020 Oct 23. iScience. 2020. PMID: 33103080 Free PMC article. Review.
-
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.Br J Cancer. 2012 Mar 27;106(7):1306-13. doi: 10.1038/bjc.2012.49. Epub 2012 Mar 13. Br J Cancer. 2012. PMID: 22415233 Free PMC article.
References
-
- Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene. 1993;8:1575–1583. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources